Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Vivacitas Oncology
AddedFeb 16, 2024
UpdatedJun 18, 2026
Vivacitas Oncology

Vivacitas Oncology

Seed

Vivacitas Oncology: Innovating biopharmaceutical solutions for resistant cancers since 2015.

HQ
Walnut Creek, CA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Vivacitas Oncology, founded in 2015 by Dr. Rubinfeld, is a biopharmaceutical company dedicated to combating cancers that are resistant to current treatment modalities. The company's core mission is to innovate and re-design well-known chemotherapies to enhance their efficacy against tough-to-treat cancers. Vivacitas Oncology focuses on developing advanced therapeutic solutions to address the unmet needs of cancer patients, aiming to improve survival rates and quality of life.

Notable affiliated individuals include co-founder Dr. Rubinfeld, who brings significant expertise to the company. Vivacitas Oncology has garnered attention for its strategic approach in re-engineering existing chemotherapies, contributing to advancements in oncology treatment. The company's impact is reflected in its commitment to addressing the challenges of resistant cancers, positioning itself as a key player in the biopharmaceutical industry focused on innovative cancer therapies.

Vivacitas Oncology - Similar Companies

Vivace Therapeutics logo

Vivace Therapeutics

OnCusp Therapeutics logo

OnCusp Therapeutics

oncusptx.com

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Cancervax logo

Cancervax

cancervax.com

Vanquish Oncology logo

Vanquish Oncology

OncoPrecision logo

OncoPrecision

oncoprecision.bio

MaveriX Oncology logo

MaveriX Oncology

OncoSpherix logo

OncoSpherix

oncospherix.com

Cullinan Oncology logo

Cullinan Oncology

Oncofactor logo

Oncofactor

oncofactor.com

Curelab Oncology logo

Curelab Oncology

OncoTartis logo

OncoTartis

OncoResponse logo

OncoResponse

NextCure logo

NextCure

nextcure.com

Clovis Oncology logo

Clovis Oncology

Vivacitas Oncology - Quick Facts

Who are Vivacitas Oncology's competitors?

Companies similar to Vivacitas Oncology include Vivace Therapeutics, OnCusp Therapeutics, Novita Pharmaceuticals and Cancervax.

When was Vivacitas Oncology founded?

Vivacitas Oncology was founded in 2015.

Where is Vivacitas Oncology's headquarters located?

Vivacitas Oncology's headquarters is located in Walnut Creek, CA, US.

When was Vivacitas Oncology's last funding round?

Vivacitas Oncology's most recent funding round was for $100k (USD) in August 2021.

How much has Vivacitas Oncology raised to-date?

As of Aug 12, 2021, Vivacitas Oncology has raised a total of $100k (USD).

How many employees does Vivacitas Oncology have?

Vivacitas Oncology has 11 employees as of Feb 5, 2024.

Vivacitas Oncology - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Therapies
Tags
  • Financial
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified